Sarepta Therapeutics, Inc.SRPTNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
6.08
↓ 96% below average
Average (9y)
167.90
Historical baseline
Range
High:1302.11
Low:6.08
CAGR
-44.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 6.08 | -15.2% |
| 2023 | 7.17 | -41.1% |
| 2022 | 12.16 | +16.6% |
| 2021 | 10.43 | -57.6% |
| 2020 | 24.61 | -1.3% |
| 2019 | 24.94 | +3.9% |
| 2018 | 24.02 | +13.4% |
| 2017 | 21.17 | -91.4% |
| 2016 | 246.33 | -81.1% |
| 2015 | 1302.11 | - |